Global Anti-Inflammaging Platform
AGENTLY
Bridging Critical
Care Science
with Longevity
Medicine
A patented multimodal selective adsorption technology removes LPS and a broad range of pro-inflammatory cytokines (IL-1β, IL-6, IL-11, IL-13, IL-18, TNFα, and others) directly from the bloodstream.
hi@agently.health